KC
TLSI icon

Kryger Capital’s TriSalus Life Sciences TLSI Stock Holding History

Kryger Capital’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-515,555
Closed -$5.12M – 25
2022
Q3 		$5.12M Sell
515,555
-623,826
-55% -$6.17M 0.69% 18
2022
Q2 		$11.2M Sell
1,139,381
-56,081
-5% -$551K 0.76% 24
2022
Q1 		$11.7M Buy
1,195,462
+755,008
+171% +$7.45M 0.67% 26
2021
Q4 		$4.35M Buy
+440,454
New +$4.38M 0.24% 85

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kryger Capital's TLSI Position: Q4 2022 in Review

Kryger Capital sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 515,555 shares — an estimated $5.12M sold.

Kryger Capital first reported a position in TLSI in Q4 2021 and held it in 4 quarters. The position peaked at $11.7M in Q1 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Kryger Capital reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Kryger Capital sold 515,555 TriSalus Life Sciences shares in Q4 2022, an estimated $5.12M.
  • Kryger Capital first reported a position in TriSalus Life Sciences in Q4 2021 and held it in 4 quarters.
  • Kryger Capital's TriSalus Life Sciences position peaked at $11.7M in Q1 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Kryger Capital's 13F filing for Q4 2022, filed 14 Feb 2023.